DNA

January 16, 2024

Following the clues through time: Old mummies, old bones and old teeth lead to new insight into disease for Katherine Van Schaik

Radiology fellow moves from present-day patients to historical artifacts to understand health and illness

By Bill Snyder
January 5, 2024

The Alliance for Genomic Discovery welcomes Bristol Myers Squibb, GSK and Novo Nordisk

Bristol Myers Squibb, GSK and Novo Nordisk are the newest members of the Alliance for Genomic Discovery.
November 15, 2023

Study finds many patients don’t seek more health services after receiving genetic screening results

A study by Vanderbilt researchers found that more than half of the patients who receive the results of genetic tests might not be impelled to seek more services than they’re already receiving.

By Paul Govern
Ann Walker, Research Assistant III, spins blood samples on a carousel prior to DNA extraction.
December 19, 2022

Vanderbilt University Medical Center’s BioVU reaches milestone with biological samples

BioVU, Vanderbilt University Medical Center’s biobank, has reached another milestone — deep-freeze storage of more than 300,000 biological samples.

By Bill Snyder
January 10, 2022

Nashville Biosciences and Illumina announce agreement to establish preeminent clinico-genomic resource for life sciences research & development

Nashville Biosciences, a wholly-owned subsidiary of Vanderbilt University Medical Center, has announced an agreement with Illumina, a leading genomic technology company, to realize the full potential of VUMC’s DNA databank, BioVU.

By Bill Snyder
January 5, 2022

Drug modifies epigenome in aggressive brain tumors: study

A folic acid-like drug changed a DNA process within brain tumors of glioblastoma patients, according to results from a phase 1 clinical trial.

By Tom Wilemon
December 16, 2021

Game theory points to new DNA data privacy solutions

Vanderbilt research is blazing a trail for the application of game theory to genomic and health data reidentification risk.
By Paul Govern
September 30, 2021

Study shows how a protein coding gene confers breast cancer susceptibility during DNA transcription

Vanderbilt-Ingram Cancer Center research is providing new insights into how genetic variants convey breast cancer susceptibility by altering the transcription factor proteins that convert DNA strands into RNA.
By Tom Wilemon
September 13, 2021

On a whim, Kaylon Bruner-Tran checked her family’s DNA. It led to family she didn’t know she had and a mother-son reunion after 50 years.

"Cultures can be very different, nothing is more powerful than family.”
By Emily Stembridge
June 18, 2020

Probing DNA damage repair

After discovering a new mechanism for DNA damage repair last year, Vanderbilt biochemists now provide direct evidence for how it works.
By Leigh MacMillan
February 6, 2020

New tool probes gene regulation

Vanderbilt biochemists got unexpected results when they used their new approach to explore the role of DNA methylation in gene regulation.
By Leigh MacMillan
October 21, 2019

Completing DNA synthesis

James Dewar and colleagues have identified a role for the enzyme topoisomerase II in reducing replication errors during the final stage of DNA synthesis.
By Leigh MacMillan
March 14, 2019

Correctly copying DNA

A precise understanding of how the enzyme topoisomerase II cuts DNA could lead to better anti-cancer therapies.
By Sanjay Mishra
1 2 3 4